Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines-Reference-Cited by-同舟云学术

Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines

Published:2008-11-04 Issue:2 Volume:118 Page:293-305
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lai Ling,Yuan Lin,Cheng Qi,Dong Chunmin,Mao Lulu,Hill Steven Marc

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-0220-1.pdf

Reference34 articles.

1. Hill SM, Blask DE (1988) Effects of the pineal hormone on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48:6121–6126

2. Ram PT, Dai J, Dong C, Kiefer TL, Lai L, Hill SM (2002) Involvment of the MT1 melatonin receptor in human breast cancer. Cancer Lett 179:141–150. doi: 10.1016/S0304-3835(01)00873-4

3. Kiefer TL, Ram PT, Yuan L (2002) Hill: melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 71:37–45. doi: 10.1023/A:1013301408464

4. Ross AW, Webster CA, Thompson M, Barrett P, Morgan PJ (1998) A novel interaction between inhibitory melatonin receptors and protein kinase C-dependent signal transduction in ovine pars tuberalis cells. Endocrinology 139:1723–1730. doi: 10.1210/en.139.4.1723

5. Giland E, Matzkin H, Zisapel N (1997) Inactivation of melatonin receptors by protein kinase C in human prostate epithelial cells. Endocrinology 138:4255–4261. doi: 10.1210/en.138.10.4255

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis;Pharmacological Reports;2023-11-23

2. Unlocking Synergistic Potential: Agomelatine Enhances the Chemotherapeutic Effect of Paclitaxel in Breast Cancer Cell Through MT1 Melatonin Receptors and ER‐alpha Axis;Chemistry & Biodiversity;2023-09-28

3. Melatonin–vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostat;Archiv der Pharmazie;2023-06-20

4. Melatonin: Translation of Ongoing Studies Into Possible Therapeutic Applications Outside Sleep Disorders;Clinical Therapeutics;2022-05

5. FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance;Journal of Medicinal Chemistry;2021-03-10